Upfront surgical resection for primary bone tumors: rationale and potential benefits

Abstract

Abstract Local control for the treatment of primary bone tumors is generally delayed following neoadjuvant chemotherapy. This was born out of the historical need to manufacture custom implants when performing limb-salvage resection. There is increasing reason to reconsider the timing of local control in the setting of primary bone tumors. In this report, we describe two cases in which upfront surgery was utilized and review rationale, prior literature, and potential benefits of this approach.

Keywords

• Upfront surgery
• Primary bone tumor
• Rhabdomyosarcoma
• Undifferentiated pleomorphic sarcoma